Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medartis Holding AGXSWX:MED -3.15%80 Days Sales Outstanding is 61.69 as of Jun. 2026, which is 6% below its 10-year median of 65.56. GuruFocus rates XSWX:MED with a GF Score™ of 80/100 and a GF Value™ of CHF106.77 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Medartis Holding AG ranks better than 55.93% on this metric.
The historical rank and industry rank for Medartis Holding AG's Days Sales Outstanding or its related term are showing as below:
XSWX:MED'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.06 Med: 65.56 Max: 72.31
Current: 61.35
During the past 12 years, Medartis Holding AG's highest Days Sales Outstanding was 72.31. The lowest was 54.06. And the median was 65.56.
XSWX:MED's Days Sales Outstanding is ranked better than 55.93% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs XSWX:MED: 61.35
Medartis Holding AG's Days Sales Outstanding
declined
from Jun. 2025 (64.91) to Jun. 2026 (61.69).
Medartis Holding AG (XSWX:MED) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Medartis Holding AG Days Sales Outstanding Related Terms
Medartis Holding AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Medartis Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Days Sales Outstanding falls into.
Medartis Holding AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a Days Sales Outstanding of 61.69 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Medartis Holding AG and its competitors. This is near median its historical median of 65.56. Over the past decade, Medartis Holding AG's Days Sales Outstanding has ranged from 54.06 to 72.31. According to the industry distribution chart, Medartis Holding AG ranks #357 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 44.1%.
Is Medartis Holding AG's Days Sales Outstanding too high?
Medartis Holding AG's current Days Sales Outstanding of 61.69 is near median its 10-year median of 65.56. Over the past 10 years, this metric has ranged from a low of 54.06 to a high of 72.31. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Medartis Holding AG's value of 61.69 is 5.6% below this industry median. Based on the distribution chart, Medartis Holding AG ranks #357 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #357 out of 810 companies for Days Sales Outstanding. This puts Medartis Holding AG in the upper half of its industry. The industry median Days Sales Outstanding is 65.38. Medartis Holding AG's value of 61.69 is 5.6% below this benchmark. Historically, Medartis Holding AG's own Days Sales Outstanding has ranged from 54.06 to 72.31 over the past decade. While the company's 10-year median is 65.56 vs. the industry median of 65.38, Medartis Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Days Sales Outstanding of 61.69 is 5.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Days Sales Outstanding is 61.69, which is near median its own 10-year median of 65.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.77, compared to a current price of CHF89.10 — trading 16.5% below its estimated fair value. The current Days Sales Outstanding is 61.69, which is near median its 10-year median of 65.56 and 5.6% below the Medical Devices & Instruments industry median of 65.38. Medartis Holding AG's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Days Sales Outstanding is 61.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF89.10 is trading 16.5% below its estimated GF Value™ of CHF106.77.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Days Sales Outstanding: 61.69 (near median its 10-year median of 65.56)
GF Value™: CHF106.77 vs. price of CHF89.10 (16.5% below fair value)
Industry Position: 5.6% below the Medical Devices & Instruments median (#357 of 810)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
80GF Score
Get the complete analysis for XSWX:MED
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
